PLAU and cancer: Among them, the proteolytic cascade system of plasminogen activation, directed by the urokinase-type plasminogen activator (uPA) and its receptor (uPAR), has long been recognized as the one that performs a central role in cancer invasion, mainly due to uPAR's capability to concentrate and increase uPA's proteolitic activity on cell surface.